Failure to Thrive

Overview

Failure to thrive (FTT) is a sign, not a diagnosis. It indicates inadequate growth compared to peers — a signal that the child's energy balance, metabolic homeostasis, or psychosocial environment is failing to support normal somatic growth. The modern UK term is faltering growth, adopted by NICE (NG75, 2017) to reduce stigma and shift clinical emphasis toward early identification and intervention rather than labelling. FTT demands the same systematic rigour as any other paediatric presentation: a structured history, accurate anthropometry plotted on validated growth charts, targeted (not blanket) investigation, and a coordinated multidisciplinary response. [1]

[1]

The clinical importance of FTT is threefold. First, growth in the first 1000 days (conception to age 2) reflects and drives brain development — early growth faltering correlates with long-term cognitive, behavioural, and academic deficits that may be irreversible. Second, FTT is frequently the presenting feature of serious underlying organic disease — coeliac disease, cystic fibrosis, congenital heart disease, and inborn errors of metabolism may all declare themselves first as poor weight gain. Third, non-organic FTT is a sentinel marker of psychosocial adversity — poverty, food insecurity, parental mental illness, and neglect — and may be the child's only route to safeguarding protection. [1]

Definition and Classification

There is no single universally accepted definition. The most widely used operational criteria combine an absolute threshold with a dynamic (trajectory) component: [1]

• Weight below the 2nd or 3rd centile for age and sex (UK-WHO / WHO 2006 charts)
• Weight-for-length/height z-score below -2 (moderate malnutrition) or below -3 (severe)
• Crossing two or more centile lines downward on a validated growth chart over time
• Weight velocity below the 3rd centile (the most sensitive single criterion)
• BMI below the 2nd centile for older children [1]

NICE (NG75) defines faltering growth in early infancy as a fall across one or more weight centile spaces if birthweight was below the 9th centile, or across two or more centile spaces if birthweight was above the 9th centile — a threshold adjusted for normal postnatal weight loss and physiological "catch-down." [1]

The organic/non-organic distinction is conceptually useful but increasingly questioned: many children have both (e.g., a child with cerebral palsy whose oromotor impairment is compounded by parental depression). The modern approach treats the categories as overlapping, not mutually exclusive, and investigates all children with persistent faltering growth rather than assuming non-organic aetiology by default. [1]

A second classification divides FTT by growth pattern: [1]

Epidemiology

FTT is reported in 5-10% of children in primary care and is among the most common reasons for paediatric outpatient referral. Hospital-admitted prevalence is higher (up to 20% on paediatric wards). Risk factors cluster around socioeconomic deprivation: the strongest associations are low household income, parental unemployment, low maternal education, food insecurity, young maternal age, single parenthood, and parental mental illness (particularly postnatal depression). Premature and low-birthweight infants are over-represented. Recurrence within families is common, reflecting both shared environment and, in some cases, inherited metabolic or genetic conditions. [1]

Growth Physiology and Hormone Control

Understanding why children grow — and the endocrine orchestra that drives it — is essential to interpreting growth failure. Growth is not a single process but the net result of cellular proliferation and hypertrophy, governed by nutrition, hormones, and the genetic programme of the epiphyseal growth plate. [1]

The epiphyseal growth plate

Longitudinal bone growth occurs at the physis (epiphyseal growth plate), a cartilaginous structure between the epiphysis and metaphysis. Resting chondrocytes in the plate proliferate, hypertrophy, and are replaced by bone on the metaphyseal side in an orderly sequence. Growth ceases at puberty when sex steroids drive chondrocyte senescence and epiphyseal fusion. Any insult that reduces chondrocyte proliferation — undernutrition, chronic illness, cortisol excess, hypothyroidism — slows linear growth and, if sustained, causes permanent short stature. [1]

The growth hormone — IGF-1 axis

Growth hormone (GH), secreted by the somatotrophs of the anterior pituitary under GHRH stimulation and somatostatin inhibition, is the master regulator of postnatal linear growth. GH acts via the JAK-STAT pathway (GH receptor → JAK2 → STAT5) to stimulate the liver to produce insulin-like growth factor-1 (IGF-1, somatomedin C), which mediates most of the growth-promoting effects at the growth plate. GH also has direct anabolic and lipolytic actions. [1]

Key points for exams:

• GH is secreted in pulsatile fashion, peaking during slow-wave sleep — sleep deprivation impairs growth
• IGF-1 is the downstream effector; serum IGF-1 is a useful surrogate for GH action (low in GH deficiency, malnutrition, and chronic illness)
• IGFBP-3 (IGF-binding protein-3) is GH-dependent and used alongside IGF-1 as a screening test
• GH stimulation testing (insulin tolerance test, glucagon, clonidine) confirms deficiency [1]

Thyroid hormone

Thyroxine (T4) is essential for postnatal linear growth and brain development. It acts synergistically with GH — it upregulates GH gene transcription and potentiates IGF-1 action at the growth plate. Congenital hypothyroidism untreated causes severe stunting and intellectual disability (cretinism); acquired hypothyroidism causes growth deceleration with delayed bone age, constipation, lethargy, and delayed puberty. This is why newborn screening for congenital hypothyroidism is universal. [1]

Insulin

Insulin is a major anabolic and growth-promoting hormone. It acts through the insulin receptor and shares signalling convergence with IGF-1 (IRS-1/PI3K/AKT). Insulin deficiency (type 1 diabetes) causes weight loss despite polyphagia — a classic FTT pattern. Foetal hyperinsulinaemia (infant of diabetic mother) causes macrosomia; conversely, chronic undernutrition causes hypoinsulinaemia and catabolism. [1]

Gonadal steroids at puberty

At puberty, oestrogen (from ovaries, and from aromatisation of adrenal and testicular androgens) drives the pubertal growth spurt and then epiphyseal fusion. The paradox: oestrogen both accelerates growth (spurt) and terminates it (fusion). Testosterone contributes via aromatisation to oestrogen. In precocious puberty, early oestrogen exposure causes initial tall stature followed by premature fusion and final short stature. [1]

Nutrition and the growth-hormone resistance of starvation

Critically, malnutrition causes functional GH resistance: GH levels rise but hepatic IGF-1 production falls (the "GH resistance" of catabolism). This is why starved children have high GH but fail to grow — the substrate is unavailable. Refeeding restores IGF-1 generation and growth resumes. This is also why refeeding must be cautious (refeeding syndrome, discussed below). [1]

Summary of hormonal control

Causes by Category

A four-part pathophysiological framework (the "A-I-R-L" approach) organises virtually every cause: Adequate intake? Ingestion/absorption? Requirements increased? Losses increased? [1]

Comprehensive Differential Diagnosis by System

Gastrointestinal

Coeliac disease (prevalence ~1:100) — autoimmune enteropathy triggered by gliadin in genetically susceptible (HLA-DQ2/DQ8) individuals. Presents with FTT, chronic diarrhoea, abdominal distension, and irritability after gluten introduction (typically 6-24 months). Serology: anti-tissue transglutaminase IgA (anti-tTG) is the first-line test; always check total serum IgA to exclude IgA deficiency (false negative). Diagnosis confirmed by duodenal biopsy showing villous atrophy, crypt hyperplasia, and intraepithelial lymphocytosis (Marsh criteria). Treatment: lifelong strict gluten-free diet. Response (symptoms improve within weeks, serology normalises in 6-12 months, mucosa heals over 1-2 years). [1]

Cystic fibrosis (CF) — autosomal recessive (CFTR gene, chromosome 7, ΔF508 most common mutation). Multi-system: recurrent chest infections, steatorrhoea (pancreatic exocrine insufficiency), failure to thrive, meconium ileus at birth (10-15%), rectal prolapse, nasal polyps, salt-loss in hot weather. Diagnosis: newborn screening (immunoreactive trypsinogen → DNA analysis → sweat test); sweat chloride over 60 mmol/L is diagnostic. Treatment: pancreatic enzyme replacement (Creon), fat-soluble vitamin supplementation (A, D, E, K), high-calorie diet (120-150% RDI), CFTR modulators (elexacaftor/tezacaftor/ivacaftor — Trikafta), chest physiotherapy, antibiotics. Modern survival now exceeds 50 years. [1]

Cow's milk protein allergy (CMPA) — IgE-mediated (immediate: urticaria, vomiting, anaphylaxis) or non-IgE-mediated (delayed: eczema, bloody diarrhoea, reflux, FTT). Management: 2-6 week cow's milk exclusion trial with extensive hydrolysate (e.g., Nutramigen) or amino acid formula (Neocate); maternal dairy exclusion if breastfeeding. Most resolve by age 3-5. [1]

Gastro-oesophageal reflux disease (GERD) — common in infants due to immature lower oesophageal sphincter. Features: recurrent vomiting, irritability, arching, refusal to feed, haematemesis (oesophagitis), recurrent aspiration. Management: positioning, feed thickeners (Gaviscon infant), alginate (Domperidone rarely used — QT risk), PPI if oesophagitis. Uncomplicated reflux (the "happy spitter") does not need treatment. [1]

Inflammatory bowel disease (IBD) — Crohn disease more than ulcerative colitis causes FTT. Older children: weight loss, diarrhoea (often bloody in UC), abdominal pain, perianal disease, growth failure (Crohn can precede GI symptoms by years), delayed puberty. Diagnosis: faecal calprotectin, endoscopy/colonoscopy with biopsy, MRI enterography. [1]

Short bowel syndrome — history of bowel resection (necrotising enterocolitis, gastroschisis, volvulus, atresia). Malabsorption of variable severity depending on residual bowel length and site (ileum loss worse than jejunum). Management: PN dependence transitioning to enteral adaptation, long-term monitoring for bacterial overgrowth and micronutrient deficiency. [1]

Hirschsprung disease — congenital absence of enteric ganglion cells (aganglionosis). Chronic constipation since birth, abdominal distension, bilious vomiting, FTT. Diagnosis: rectal suction biopsy (absent ganglion cells, hypertrophied nerve trunks). Complication: enterocolitis (toxic, life-threatening). Treatment: surgical (pull-through procedure). [1]

Helicobacter pylori — chronic gastritis causing anorexia and occult blood loss; consider in recurrent abdominal pain with iron deficiency. [1]

Cardiac

Congenital heart disease (CHD) with heart failure — the cardinal mechanism is increased metabolic demand from tachypnoea and the work of breathing, compounded by poor feeding (exhaustion, diaphoresis with feeds) and malabsorption (venous congestion, protein-losing enteropathy). Lesions causing large left-to-right shunts (VSD, AVSD, PDA) are the classic culprits, presenting at 6-8 weeks when pulmonary vascular resistance falls and the shunt increases. Cyanotic lesions (TGA, TOF, tricuspid atresia) cause FTT via hypoxaemia and metabolic acidosis. Signs: tachypnoea, tachycardia, hepatomegaly, murmur, sweating with feeds, poor perfusion. Management: diuretics (furosemide 1 mg/kg/dose BD), ACE inhibitor (captopril), caloric supplementation, and definitive surgical/interventional repair. [1]

Respiratory

Cystic fibrosis (discussed above — the most important respiratory cause of FTT). Bronchopulmonary dysplasia (BPD) in premature infants causes increased work of breathing and calorie expenditure. Severe asthma (chronic under-treated) and bronchiectasis (post-infective, e.g., after adenovirus or pertussis) cause FTT via chronic inflammation and steroid side effects. [1]

Endocrine

Hypothyroidism — lethargy, constipation, dry skin, bradycardia, delayed development, prolonged jaundice (congenital), cold intolerance, delayed bone age, macroglossia, umbilical hernia (congenital). TFTs: high TSH, low free T4. Treatment: levothyroxine 10-15 mcg/kg/day (congenital), titrated to keep TSH normal. Untreated congenital hypothyroidism causes irreversible neurodevelopmental impairment — the rationale for newborn screening. [1]

Growth hormone deficiency — proportional short stature (weight, height, and head circumference equally affected but below centiles), delayed bone age, cherubic appearance, frontal bossing, central adiposity, fasting hypoglycaemia (loss of GH's counter-regulatory effect), delayed puberty. Diagnosis: low IGF-1 and IGFBP-3 (screening), confirmed by GH provocation test (failure to rise above threshold, typically below 6-7 ng/mL after stimulation — cutoff varies by assay and country). Treatment: recombinant GH subcutaneous daily (0.025-0.035 mg/kg/day). Causes include idiopathic, pituitary tumours, cranial irradiation, and genetic (PROP1, POU1F1). [1]

Cushing syndrome — exogenous steroids (most common in children — asthma, nephrotic syndrome, IBD treatment) cause growth arrest, central obesity, moon face, buffalo hump, striae, hypertension. Endogenous (rare): adrenal adenoma/carcinoma, Cushing disease (pituitary adenoma). Mechanism: cortisol suppresses GH secretion and IGF-1, and directly inhibits chondrocyte proliferation. [1]

Adrenal insufficiency — fatigue, hyperpigmentation (primary — high ACTH/MSH), hypotension, hypoglycaemia, salt-craving, hyponatraemia/hyperkalaemia. Congenital adrenal hyperplasia (21-hydroxylase deficiency) presents in the neonate with salt-wasting crisis; presenting FTT in an older child raises the possibility of non-classical CAH. [1]

Type 1 diabetes mellitus — polyuria, polydipsia, polyphagia with weight loss (the classic tetrad). The child is eating voraciously yet losing weight due to insulin deficiency and catabolism. May present in DKA. Diagnosis: random glucose over 11.1 mmol/L with symptoms, or HbA1c over 6.5%. [1]

Renal

Chronic kidney disease (CKD) — poor growth from anorexia, metabolic acidosis, renal osteodystrophy, electrolyte disturbance, growth hormone resistance (uraemic), and anaemia (low erythropoietin). Features: pallor, lethargy, oedema, hypertension, delayed puberty. Diagnosis: U&E, creatinine, eGFR, bicarbonate, phosphate, PTH, renal ultrasound. Management: phosphate binders, bicarbonate, active vitamin D (alfacalcidol), erythropoietin, growth hormone, and ultimately renal replacement therapy. [1]

Renal tubular acidosis (RTA) — FTT with metabolic acidosis (low bicarbonate) and inappropriately alkaline urine (urinary pH above 5.5). Type 1 (distal) and type 2 (proximal) both cause growth failure; type 2 may have Fanconi syndrome (glycosuria, aminoaciduria, phosphaturia). Diagnosis: venous blood gas (normal anion gap metabolic acidosis), urinary pH. Treatment: oral bicarbonate supplementation (2-4 mEq/kg/day proximal, 1-2 mEq/kg/day distal). [1]

Nephrogenic diabetes insipidus — polyuria, polydipsia, FTT from water loss and caloric dilution. Diagnosis: water deprivation test (failure to concentrate urine), desmopressin non-response (nephrogenic). [1]

Infectious

Tuberculosis — chronic cough, night sweats, weight loss, fever, lymphadenopathy; consider in high-prevalence populations and contact tracing. HIV — recurrent infections, chronic diarrhoea, FTT, lymphadenopathy, oral candidiasis; vertical transmission. Intestinal parasitism — giardiasis (malabsorption), hookworm (iron deficiency anaemia), ascariasis. Recurrent UTI — occult, may present only as FTT; urine MC&S essential. Chronic hepatitis — hepatosplenomegaly, jaundice. [1]

Genetic and Metabolic

Down syndrome (trisomy 21) — hypotonia, brachycephaly, epicanthal folds, single palmar crease, congenital heart disease (AVSD), duodenal atresia, hypothyroidism — all contribute to growth restriction. Growth charts specific to Down syndrome exist. Turner syndrome (45,X) — short stature (SHOX gene haploinsufficiency), webbed neck, shield chest, coarctation, delayed puberty; treated with GH. Prader-Willi syndrome (15q11-q13 deletion, paternal) — neonatal hypotonia and poor feeding, later hyperphagia and obesity, short stature, intellectual disability, hypogonadism. Russell-Silver syndrome — intrauterine and postnatal growth restriction, asymmetry, triangular face. Noonan syndrome — short stature, webbed neck, pulmonary stenosis, characteristic facies. [1]

Inborn errors of metabolism — galactosaemia (jaundice, hepatomegaly, cataracts, FTT on lactose), phenylketonuria (untreated — microcephaly, intellectual disability, FTT), glycogen storage diseases (hepatomegaly, hypoglycaemia, hyperlipidaemia), lysosomal storage disorders (organomegaly, developmental regression). Most are detected on newborn blood spot screening. [1]

Neurological

Cerebral palsy (CP) — oromotor dysfunction (sucking, swallowing, chewing difficulty), gastro-oesophageal reflux, constipation, and high calorie expenditure from spasticity all cause FTT. Feeding assessment by speech and language therapy is essential; many require gastrostomy feeding. Neuromuscular disease (spinal muscular atrophy, muscular dystrophy) — weakness impairs feeding and breathing; scoliosis compromises respiratory function and increases energy expenditure. [1]

Iatrogenic and Drug-related

Excessive fruit juice (sorbitol-induced diarrhoea, caloric dilution), restrictive diets (vegan without supplementation — B12 deficiency), medication side effects (stimulants for ADHD causing anorexia), mismanaged complementary feeding (excessive milk, delayed textures). [1]

Growth Chart Interpretation

Accurate growth chart interpretation is the single most important clinical skill in FTT. Without it, neither diagnosis nor monitoring is possible. [1]

Which chart?

In the UK, the UK-WHO growth charts (Royal College of Paediatrics and Child Health, RCPCH) are standard. They use WHO 2006 multi-centre growth reference data (breastfed infants from 6 countries) from 2 weeks to 4 years, and UK 1990 reference data from 4 years onward and for term infants from birth to 2 weeks. Preterm infants use UK-WHO preterm or Fenton charts. Children with specific syndromes (Down, Turner, Noonan, achondroplasia) have condition-specific charts. Use of the wrong chart is a common and serious error — always confirm age, sex, and gestation before plotting. [1]

What to plot

Three parameters at every visit: weight, length/height (length under 2 years lying supine; height over 2 years standing), and head circumference (routine until age 2, or longer if concern). Plotting all three on the same chart allows pattern recognition. [1]

Weight velocity

• 0-3 months: 20-30 g/day (approximately 200 g/week)
• 3-6 months: 15-20 g/day (approximately 100-150 g/week)
• 6-12 months: 10 g/day
• 1-3 years: 5-8 g/day
• School-age: 2-3 kg/year [1]

Weight gain below the 3rd centile for velocity (the "thrive lines" on UK-WHO charts) over an 8-12 week period is the most sensitive indicator of FTT. Thrive lines are diagonal lines drawn on the chart; if weight falls below the relevant thrive line, growth velocity is abnormal. [1]

Height velocity

• Birth to 2 years: approximately 2 cm/month (25 cm in first year)
• 2 years to puberty: 5-6 cm/year
• Puberty (peak height velocity): 8-12 cm/year (girls earlier, Tanner stage 3; boys later, Tanner stage 4) [1]

Height velocity below 5 cm/year after age 2 warrants endocrine evaluation. [1]

Head circumference velocity

• 0-3 months: 2 cm/month
• 3-6 months: 1 cm/month
• 6-12 months: 0.5 cm/month
• First year total: 12 cm; second year total: 6 cm [1]

A head circumference crossing centiles downward suggests chronic severe undernutrition affecting brain growth, or a primary neurological/genetic cause. [1]

Crossing centiles — what is normal, what is not

Infants do not grow along a single centile from birth. Three physiological patterns must be recognised: [1]

1. Postnatal weight loss and recovery: term infants lose up to 10% birthweight in the first week, regaining it by 10-14 days. This is normal.
2. Catch-down (regression to the mean): infants whose birthweight was high (e.g., above 90th centile, often due to maternal factors — gestational diabetes) may legitimately cross one or two centiles downward over the first few months to their genetic trajectory. Conversely, small-for-gestational-age infants may "catch up" upward.
3. Catch-up growth: after a period of growth restriction (prematurity, illness), growth velocity may exceed normal to return to the centile trajectory. [1]

Pathological centile crossing: crossing two or more centile lines downward after age 6 months (when physiological catch-down is largely complete), or any downward crossing that is sustained and progressive, demands investigation. Always confirm with repeat measurement (different visit, ideally different measurer) to exclude error. [1]

Measurement error — the silent saboteur

Before diagnosing FTT on a single chart, exclude: different scales (calibrate regularly), clothing/shoes (weigh in minimal clothing), time of day (weigh at same time), different measurers (inter-observer variation in length is substantial), recent illness (acute gastroenteritis can drop weight transiently — re-measure after recovery). The RCPCH recommends plotting at every health visit and in any unwell child. [1]

Practical interpretation rules

• Weight faltering before height = recent/acute nutritional deficit
• Height affected before or equally with weight = chronic undernutrition or endocrine (GH deficiency, hypothyroidism)
• Head circumference preserved, weight and height low = non-organic / undernutrition (brain protected)
• All three low = chronic severe, congenital, or genetic
• Disproportionate (height much more affected than weight) = endocrine, skeletal dysplasia
• Velocity below normal is more sensitive than any single point measurement [1]

Clinical Assessment

History

A meticulous history is the highest-yield investigation. Structure it around the A-I-R-L framework. [1]

Feeding/dietary history:

• Breastfeeding: latch, supply, frequency, duration, maternal concerns
• Formula: type, volume per feed, frequency, preparation (over-dilution? — a classic cause), total daily volume
• Weaning/complementary feeding: age introduced, textures accepted, variety, food refusal
• Mealtime behaviour: duration (over 30 minutes suggests difficulty), refusal, grazing, distractions (TV/screens)
• Intake of milk, juice, water — excessive milk (over 500 mL/day in toddlers) is a common culprit
• Supplements (vitamin D, iron) [1]

Pregnancy and birth:

• Gestational age, birthweight (plot on preterm chart if relevant), complications (pre-eclampsia, IUGR), mode of delivery, neonatal course (NICU, oxygen, feeding) [1]

Developmental history:

• Milestones — delay may indicate underlying neurological/genetic cause; regression is a red flag [1]

Past medical and surgical:

• Recurrent infections (chest, UTI), hospitalisations, operations, chronic illness, medications [1]

Family and social:

• Parental heights (calculate mid-parental height — target centile: (father height + mother height ± 13 cm for boys/girls) / 2 ± 8.5 cm), sibling growth, consanguinity, inherited conditions
• Social history is pivotal: income, housing, benefits, food insecurity, parental mental health, substance misuse, domestic violence, social support, safeguarding history [1]

Examination

Growth parameters: weight, length/height, head circumference, BMI — all plotted. Dysmorphic features (syndromic facies). Nutritional status: muscle wasting (deltoid, gluteal), subcutaneous fat (triceps skinfold), skin/hair changes (dry, sparse, easily pluckable hair; dry skin in hypothyroidism; dermatitis in zinc/essential fatty acid deficiency), angular stomatitis (B vitamin), koilonychia (iron). Hydration: sunken fontanelle, reduced skin turgor, dry mucosae. [1]

Systemic examination:

• Cardiac: murmur (CHD), tachypnoea, hepatomegaly, sweating with feeds (heart failure)
• Respiratory: wheeze, crackles, clubbing (CF, bronchiectasis), chest deformity
• Abdomen: distension (coeliac, Hirschsprung, malnutrition/kwashiorkor), hepatosplenomegaly (storage disease, infection), masses, perianal disease (IBD)
• Neurological: tone, power, reflexes (CP, neuromuscular disease), development
• Skin: bruising, scars (safeguarding), eczema (allergy), rash (systemic disease) [1]

Mid-parental height (target height) calculation

For a boy: (father's height + mother's height + 13 cm) / 2, ± 8.5 cm. For a girl: (father's height + mother's height − 13 cm) / 2, ± 8.5 cm. [1]

This defines the child's genetic target range; growth outside this range suggests pathology. [1]

Investigations — Targeted, Not Blanket

The evidence is clear: blanket screening panels in FTT are low-yield and generate false positives. NICE recommends testing guided by history and examination. The core screen for all children with persistent faltering growth: [1]

Second-line, guided by clinical suspicion:

• Sweat test — if CF suspected (recurrent chest, steatorrhoea, meconium ileus)
• Stool — fat globules/Sudan stain (malabsorption), ova/cysts/parasites, faecal calprotectin (IBD), faecal elastase (pancreatic insufficiency — CF), faecal reducing substances (carbohydrate malabsorption)
• Echo — murmur, heart failure signs, CHD suspected
• IGF-1, IGFBP-3 then GH provocation test — GH deficiency (after excluding undernutrition — GH testing in a starved child is meaningless as IGF-1 is low from starvation)
• Karyotype / microarray / genetic panel — syndromic suspicion
• HIV test — risk factors, recurrent infection
• Chest X-ray — TB, chronic lung disease, cardiomegaly
• Barium/contrast swallow, pH/impedance study — GERD, malrotation
• Upper GI endoscopy with biopsy — coeliac (Marsh grading), IBD, eosinophilic oesophagitis
• Skull X-ray / pituitary MRI — GH deficiency (pituitary lesion)
• Bone age (X-ray left hand/wrist) — delayed in GH deficiency, hypothyroidism, constitutional delay; advanced in precocious puberty [1]

Detailed Nutritional Assessment

3-Day Food Diary Analysis

A comprehensive feeding assessment is the cornerstone of non-organic FTT evaluation. The 3-day food diary should include: [1]

Information required:

• All foods and drinks consumed (including snacks, supplements, snacks "stolen")
• Portion sizes (use household measures — tablespoons, cups; or, better, weigh)
• Timing of meals and snacks
• Mealtime environment (TV on? family meals? distractions?)
• Child's behaviour during meals (cooperative? refusing? tantrums? duration?)
• Parental response to food refusal (pressure to eat? giving up? alternative foods offered?)
• One weekend day included (routines differ) [1]

Nutritional analysis (with dietitian):

• Total caloric intake (compare to Estimated Average Requirement: approximately 100-120 kcal/kg/day for children 1-3 years, 80-90 kcal/kg/day for 4-6 years)
• Protein intake (approximately 1.1 g/kg/day for 1-3 years; 0.9 g/kg/day for 4-13 years)
• Micronutrient adequacy (iron, calcium, vitamin D, zinc, B12)
• Fluid intake (adequate? excessive milk/juice displacing food?)
• Distribution of macronutrients (fat should not be overly restricted in under-2s — essential for brain growth) [1]

Common feeding problems identified by diary:

• Excessive milk consumption (over 500 mL/day in toddlers) — fills the child, displaces solids; also causes iron deficiency anaemia (milk inhibits iron absorption and causes occult GI blood loss). Treat: reduce to under 400 mL/day, offer solids first.
• Excessive juice consumption — sugar and sorbitol cause diarrhoea and caloric dilution.
• Grazing/snacking pattern — child never hungry for meals; frequent low-nutrient snacks.
• Parental pressure to eat — creates negative association, food refusal as a control battle.
• Mealtime battles, TV/screens during meals — distract from hunger cues, prolong mealtimes.
• Late introduction of textures/lumpy foods — causes oral aversion and gag reflex persistence.
• Mismanaged weaning — delayed or restricted variety.
• Over-diluted formula — a classic cause of under-caloric feeding (and water intoxication).
• Restrictive diets — well-intentioned but nutritionally inadequate (vegan without B12, "healthy" low-fat diets in under-5s). [1]

Management — Principles and MDT Approach

The overarching principle: treat the cause when identified; in all cases, ensure adequate nutrition. Non-organic FTT does not mean the child does not have FTT — the growth failure is real and the nutritional rehabilitation is identical. The difference is the aetiology, not the seriousness. [1]

Core MDT team

• Paediatrician: overall coordination, medical assessment, investigations, diagnosis of organic causes
• Dietitian: nutritional assessment (food diary analysis), caloric calculation, feeding plan, supplement selection, NG/gastrostomy feeding regimen
• Health visitor: home visit, feeding observation in the home environment, parental education, safeguarding liaison, coordination with primary care
• Speech and language therapist: oromotor/feeding assessment (especially for texture aversion, swallowing difficulty, CP)
• Psychologist / CAMHS: parental mental health (postnatal depression), parent-child interaction, behavioural feeding interventions, attachment assessment
• Social worker: safeguarding assessment, family support, practical help (benefits, housing, food vouchers)
• Specialist nurse: community follow-up, weight monitoring, care coordination [1]

Nutritional rehabilitation plan

The goal is catch-up growth — growth above normal velocity to recover the deficit. This requires 120-150% of the Estimated Average Requirement for the child's age. [1]

Stepwise approach: [1]

1. Dietary modification: energy-dense foods — add butter, cream, cheese, oil, peanut butter, avocado to meals; offer 3 meals + 2-3 snacks; reduce milk to under 400 mL/day in over-1s; ensure variety and texture progression; avoid "low-fat" anything in under-5s
2. Oral nutritional supplements: Fortisip (1.5 kcal/mL), Paediasure (1 kcal/mL), Frebini — prescribed when dietary modification insufficient; given between meals (not as meal replacement); rotate flavours to prevent fatigue
3. Enteral tube feeding: NG (nasogastric) feeding if oral intake inadequate despite supplements — can be overnight (bolus or continuous) to supplement daytime intake, or total; gastrostomy if long-term (over 6-12 months) likely (e.g., CP, neurodisability)
4. Parenteral nutrition: rarely needed in non-organic FTT; reserved for short bowel syndrome, severe malabsorption, inpatient [1]

Calorie calculation for catch-up growth: [1]

Catch-up requirement (kcal/kg/day) = EAR (kcal/kg/day) × [desired weight centile / actual weight] [1]

In practice, aim for 120-150% of EAR and titrate against weight gain. Target weight gain: 10-15 g/kg/day for catch-up in infants (0-6 months), 5-10 g/kg/day (6-12 months), 2-3 g/kg/day in toddlers. [1]

Micronutrients: supplement vitamin D (400 IU/day universally in UK for under-5s), iron if deficient, and a complete multivitamin during catch-up. Zinc supplementation improves appetite and growth in deficient children. [1]

Behavioural and family interventions

For non-organic FTT, behavioural feeding interventions are as important as calories:

• Establish regular mealtime routines (3 meals + 2-3 snacks, 20-30 minute meals, eat together)
• Remove distractions (TV, screens, toys)
• Positive reinforcement for eating; avoid pressure, coercion, or punishment for refusal
• Offer small portions of varied food; let the child self-feed where developmentally able
• Parent training to reduce mealtime conflict
• Treat parental mental illness (postnatal depression — this alone can transform feeding)
• Practical support: food vouchers, benefits advice, housing, cooking facilities [1]

WHO Management of Severe Acute Malnutrition (SAM)

When FTT has progressed to severe acute malnutrition, specialised inpatient management follows the WHO 10-step protocol. This applies in resource-limited settings and to severe cases worldwide (e.g., severe neglect, eating disorders, chronic disease decompensation). [1]

Criteria for SAM (admit to therapeutic feeding programme)

• Weight-for-height z-score below -3 (WHO 2006 standards)
• MUAC (mid-upper arm circumference) below 11.5 cm (6-59 months)
• Bilateral pitting oedema of nutritional origin (kwashiorkor — severe acute malnutrition with oedema)
• MUAC 11.5-12.4 cm = moderate acute malnutrition (MAM) [1]

The WHO 10-step protocol

Phase 1: Stabilisation (days 1-7) — treat the immediate threats to life [1]

1. Treat/prevent hypoglycaemia: blood glucose below 3 mmol/L is dangerous. Feed F-75 (75 kcal/100 mL) every 2-3 hours day and night. If hypoglycaemic, give IV 10% glucose (5 mL/kg bolus) then continue feeds. Never let the child go more than a few hours without feed in the stabilisation phase.
2. Treat/prevent hypothermia: keep warm, maintain temperature above 35.5°C; kangaroo mother care for infants; check temperature 2-hourly. Hypoglycaemia and hypothermia often coexist (both reflect metabolic decompensation).
3. Treat/prevent dehydration: use ReSoMal (reduced osmolarity oral rehydration solution for malnutrition — lower sodium, higher potassium than standard ORS). Avoid IV fluids unless in shock — malnourished children tolerate fluid poorly (heart failure risk). Rehydrate slowly (5 mL/kg every 30 min for first 2 hours, then 5-10 mL/kg alternate hours for 4-10 hours).
4. Correct electrolyte imbalance: all severely malnourished children are deficient in potassium and magnesium and have excess total body sodium (despite often appearing hyponatraemic — intracellular sodium excess). F-75 is formulated low-sodium, high-potassium. Give potassium 3-4 mmol/kg/day and magnesium for at least 2 weeks. Do NOT give diuretics for oedema — the oedema is not fluid overload.
5. Treat/prevent infection: all severely malnourished children should receive broad-spectrum antibiotics empirically — infection is often occult (impaired inflammatory response). Use amoxicillin (15 mg/kg BD-TDS PO) + gentamicin (7.5 mg/kg OD IV/IM) for severe; add metronidazole if sepsis/anaerobic suspicion. Give measles vaccine at admission if over 9 months and unimmunised (after stabilisation). Tuberculosis and HIV are common co-infections — screen.
6. Correct micronutrient deficiencies: give vitamin A (50,000-200,000 IU by age on day 1, repeated days 2 and 14 if eye signs), zinc (2 mg/kg/day), copper, folic acid (5 mg day 1 then 1 mg/day). Do NOT give iron during the acute phase — it can worsen infection and precipitate free-radical injury; give only once the child is stable and gaining weight (typically after 7 days, at 3 mg/kg/day). F-75 and F-100 contain balanced micronutrients.
7. Begin cautious feeding (stabilisation): F-75 (75 kcal/100 mL) — 75 kcal/kg/day, 100 mL/kg/day fluid. Feed every 2-3 hours (8-12 feeds/24h). The goal is metabolic stabilisation, NOT weight gain. F-75 is deliberately low-calorie to avoid overwhelming metabolic capacity (refeeding syndrome). Children stabilise over 3-7 days; oedema begins to reduce, appetite returns, infection resolves. [1]

Phase 2: Rehabilitation (days 7 onwards — transition and catch-up) [1]

8. Transition carefully to rehabilitation feed: when the child is stable (appetite returning, oedema reducing, no complications), begin transitioning to F-100 (100 kcal/100 mL) or ready-to-use therapeutic food (RUTF, Plumpy'Nut). Transition gradually over 2-3 days — replace F-75 with F-100 one feed at a time, while monitoring for fluid overload and heart failure (sodium load changes). RUTF (Plumpy'Nut) is a lipid-based, water-free paste (peanut, milk powder, oil, sugar, micronutrients) that does not require refrigeration and can be used at home — central to community-based management of acute malnutrition (CMAM).
9. Provide sensory stimulation and emotional support: severely malnourished children are often withdrawn, apathetic, and developmentally delayed. Provide structured play, physical affection, talk, and developmental stimulation. Involve the mother/caregiver. Without this, catch-up is incomplete even when nutrition is restored.
10. Prepare for discharge and follow-up: criteria for discharge — weight-for-height reaching -2 SD (z-score above -2), no oedema for 2 weeks, weight gain of at least 5 g/kg/day for 3 successive weighings, clinically well. Provide nutritional counselling, link to supplementary feeding, immunisation, and follow-up at 1, 2, 4 weeks then monthly until recovered. Relapse prevention: address food security, infection, and underlying disease. [1]

Refeeding syndrome — pathophysiology and prevention

Refeeding syndrome is a potentially fatal metabolic complication that occurs when feeding resumes after a period of starvation or severe undernutrition. [1]

Pathophysiology: During starvation, insulin is low and the body catabolises fat and protein. Electrolytes (phosphate, potassium, magnesium) are depleted intracellularly but serum levels may appear normal (the deficit is masked). When carbohydrates are reintroduced, insulin surges, driving phosphate, potassium, and magnesium into cells (for glycolysis and ATP synthesis), causing acute hypophosphataemia, hypokalaemia, and hypomagnesaemia. The consequences: cellular ATP depletion, cardiac arrhythmias, respiratory failure (diaphragmatic weakness), rhabdomyolysis, seizures, confusion, fluid retention and heart failure, and Wernicke encephalopathy (thiamine depletion by carbohydrate metabolism). [1]

Children at highest risk: severe undernutrition (under 70% expected weight), minimal intake for over 10 days, low baseline phosphate/potassium/magnesium, chronic antacid/diuretic use, alcohol misuse, oncology patients. [1]

Prevention protocol:

• Start feeding at 10-20 kcal/kg/day (not full requirement), increase gradually over 5-7 days
• Give thiamine 100 mg daily (or 200-300 mg) before and during the first week of feeding
• Supplement phosphate, potassium, magnesium prophylactically and correct deficits
• Monitor: phosphate, potassium, magnesium, calcium, sodium daily (at least for first week, more often if high risk); ECG if abnormal
• Fluid: restrict to two-thirds maintenance; avoid rapid saline boluses
• Have a written refeeding protocol on every ward [1]

Safeguarding Assessment Framework

Non-organic FTT may be the only presentation of child neglect — the most common form of child maltreatment and a major contributor to growth failure. Up to 10% of severe FTT cases have a safeguarding component. A structured safeguarding assessment is mandatory whenever there are red flags or the FTT is unexplained after adequate assessment. [1]

When to suspect safeguarding concerns

Exam application bank (NEET-PG / INICET)

One-line answer

Failure to thrive (FTT) = weight consistently below the 3rd centile or crossing 2 major centile lines downward. Preferred term: faltering growth. Affects 5-10% of children. Classification: organic (identifiable pathology) vs non-organic/psychosocial (most common, 70-80%). Causes: inadequate intake, malabsorption (coeliac, CF), increased requirements (CHD), increased losses (GERD). Management: MDT approach (dietitian, health visitor, paediatrician), nutritional rehabilitation.

Worked stems (answer without another resource)

Stem 1 — Classic presentation. Map symptoms to mechanism; name the first investigation and first treatment step with dose/route if drug therapy is standard. [1]

Stem 2 — Unstable / complicated. List red flags that force immediate resuscitation, theatre, ICU, antidote, or reperfusion — and what you do in the first 15 minutes. [1]

Stem 3 — Atypical group. Elderly, pregnancy, child, or immunocompromised: how presentation and thresholds change. [1]

Stem 4 — Differential trap. Name the three closest mimics and one discriminator for each. [1]

Stem 5 — Disposition. Who goes home with safety-netting, who is admitted, who needs HDU/ICU/theatre, and what follow-up is mandatory. [1]

Rapid viva checklist

1. Definition + classification
2. Pathophysiology chain
3. Bedside signs / criteria
4. Score with exact components (if any)
5. Emergency bundle
6. Definitive therapy with doses
7. Complications of disease and of treatment
8. Special populations
9. Guideline/trial name if classic
10. Three exam traps

Coverage self-check

If you cannot answer any stem above from this page alone, re-read the matching section — the page is intended to be self-sufficient for final-prof and NEET-PG/INICET questions on Failure to Thrive.

[1]

Framework for assessment (UK)

Use the Assessment Framework Triangle (Children Act 1989, Working Together 2023), assessing three domains: [1]

1. Child's developmental needs:

• Health (growth, immunisation, illness), education, emotional and behavioural development, identity, family and social relationships, social presentation, self-care skills [1]

2. Parenting capacity:

• Basic care (feeding, hygiene, warmth), ensuring safety, emotional warmth, stimulation, guidance and boundaries, stability [1]

3. Family and environmental factors:

• Family history and functioning, wider family, housing, employment, income, family's social integration, community resources [1]

A deficiency in parenting capacity (especially basic care — providing adequate food) in the context of FTT, particularly with red flags, mandates safeguarding referral. [1]

Action pathway

1. Discuss with the named/designated safeguarding lead within the organisation
2. Information-sharing: liaise with GP, health visitor, school nurse, social care (with appropriate consent; share without consent if risk of significant harm)
3. Refer to children's social care if neglect suspected — under Section 47 (child protection enquiry) if significant harm suspected, or Section 17 (child in need) for support
4. Strategy discussion (multi-agency — social care, police, health) if Section 47
5. Child protection conference if concerns substantiated — may lead to a child protection plan or, in severe cases, removal into care (Emergency Protection Order, Care Order)
6. Admission to a "place of safety" or hospital for the diagnostic therapeutic trial (does the child grow when adequately fed in a nurturing environment?) — catch-up growth in hospital strongly supports non-organic/neglect aetiology [1]

The threshold for referral should be low: it is better to over-refer and be reassured than to miss ongoing neglect. Document meticulously — contemporaneous records may be needed in court. [1]

Psychological Assessment

Parental and child psychological factors are central to non-organic FTT and must be assessed as rigorously as organic causes. [1]

Parental mental health:

• Postnatal depression — screen with the Edinburgh Postnatal Depression Scale (EPDS); a score over 13 suggests depression. Maternal depression impairs responsive feeding and attachment and is a major, reversible cause of FTT.
• Anxiety, eating disorder history (maternal anorexia can distort feeding practice), substance misuse, intellectual disability, domestic violence, history of being neglected themselves (intergenerational transmission) [1]

Parent-child interaction / attachment:

• Observe a mealtime: is the parent attuned to the child's hunger and satiety cues? Responsive? Or controlling, intrusive, or disengaged? Disorganised or insecure attachment is common in FTT.
• Video feedback intervention (e.g., Video Interaction Guidance) improves sensitive responsiveness. [1]

Child factors:

• Temperament (fussy eater, easily distracted, sensory sensitivities)
• Developmental stage (toddler autonomy seeking — food refusal as control)
• Sensory processing (food texture aversion, oral hypersensitivity — common in ex-preterm, autistic spectrum)
• Underlying neurodevelopmental condition (autism, ADHD, learning disability) [1]

Assessment tools:

• Edinburgh Postnatal Depression Scale (mother) — 10-item self-report
• Parent-Child Relationship Assessment — observe mealtime interaction
• Home visit (health visitor) — assess food availability, cooking facilities, family dynamics, the home environment
• Ages and Stages Questionnaire (ASQ) — developmental screening
• Consider CAMHS referral for parental mental health or child behavioural feeding disorders [1]

Long-term Outcomes

The prognosis of FTT is critically dependent on timing, duration, cause, and adequacy of intervention. Growth in the first 1000 days (conception to age 2) is uniquely important because it overlaps with the most rapid phase of brain development. [1]

Non-organic FTT

• With early, adequate nutritional intervention and family support: excellent — most children catch up by school age with no long-term sequelae
• Persistent neglect without intervention: cognitive impairment (IQ deficits of 5-15 points in severe, prolonged cases), behavioural problems (attention, conduct), short stature persisting into adulthood, poorer educational attainment and employment outcomes
• Early intervention is critical — the brain growth most rapid in the first 2 years is the most vulnerable and the least recoverable [1]

Organic FTT

Depends entirely on the underlying condition and its treatability:

• Coeliac disease: excellent with gluten-free diet — catch-up growth complete if treated early; untreated, increased risk of lymphoma, osteoporosis, infertility
• Cystic fibrosis: variable — improved dramatically with CFTR modulators; median survival now exceeds 50 years; growth improves with pancreatic enzyme replacement and aggressive nutrition
• Congenital heart disease: depends on lesion and timing of repair — early complete repair normalises growth; unrepaired complex lesions carry poor prognosis
• Growth hormone deficiency: excellent with recombinant GH — near-normal final height if treated early; bone age monitoring guides duration
• Hypothyroidism: excellent with levothyroxine if detected early (newborn screening); late detection causes irreversible neurodevelopmental harm
• Inborn errors of metabolism: often guarded — depends on specific disorder and diet responsiveness
• Chronic kidney disease: growth improves with transplantation; GH therapy used [1]

Monitoring and follow-up

• Weekly weighing during active treatment and refeeding
• Fortnightly once on a stable plan
• Monthly when improving
• Growth velocity more important than single measurements — plot and review trajectory
• Head circumference should improve with nutritional rehabilitation (if it does not, suspect chronicity or primary cause)
• Developmental review at every visit — refer for early intervention services if delay identified
• Transition to adult services for chronic conditions (CF, CKD, metabolic disorders) [1]

Complications

Untreated or severe FTT carries significant morbidity: [1]

• Cognitive and neurodevelopmental impairment — the most important and potentially irreversible; severity correlates with duration and severity of undernutrition, especially in the first 2 years
• Immune compromise — malnourished children have impaired cell-mediated and humoral immunity; increased susceptibility to severe infection (pneumonia, sepsis, measles, TB) and higher case fatality
• Recurrent infections — which in turn worsen nutritional status (vicious cycle)
• Micronutrient deficiencies — iron (anaemia, developmental), zinc (dermatitis, impaired healing, diarrhoea), vitamin A (xerophthalmia, blindness), vitamin D (rickets), B12 (megaloblastic anaemia, neuropathy)
• Refeeding syndrome (see above) — iatrogenic but preventable
• Hypothermia, hypoglycaemia — in severe malnutrition
• Cardiac — bradycardia, heart failure (especially during refeeding), QT prolongation from electrolyte disturbance
• Psychosocial — attachment disorders, behavioural problems, long-term mental health sequelae [1]

Exam Tips and Common Pitfalls

High-yield exam points:

• FTT is a sign, not a diagnosis — always seek the underlying cause
• The commonest cause overall is non-organic (inadequate intake) — but never assume; investigate persistent cases
• Velocity is more important than single measurement — "one swallow does not make a summer"
• Head circumference preserved with low weight/height suggests non-organic; all three affected suggests chronic/organic
• Crossing two centiles downward after the physiological catch-down period (beyond 6 months) is the key trigger for investigation
• Coeliac serology: anti-tTG IgA plus total IgA — always check for IgA deficiency
• Sweat chloride over 60 mmol/L diagnoses cystic fibrosis
• Functional GH resistance in starvation — IGF-1 is low in any starved child; do not over-diagnose GH deficiency in malnutrition
• F-75 stabilises, F-100 rehabilitates — do not jump to F-100 (refeeding syndrome)
• Iron is withheld in the acute phase of SAM — give after stabilisation
• ReSoMal (not standard ORS) for dehydration in SAM — lower sodium
• Never give diuretics for kwashiorkor oedema — the oedema is not fluid overload
• Refeeding syndrome: phosphate, potassium, magnesium crash — start low, go slow, give thiamine
• Mid-parental height calculation is a favourite viva question — practise it
• Safeguarding referral threshold is low — document meticulously [1]

Common pitfalls:

• Over-diagnosing FTT on a single weight (always confirm with velocity and exclude measurement error)
• Forgetting to plot head circumference
• Ordering a "blanket" investigation panel rather than targeted tests
• Missing coeliac disease because total IgA was not checked (false-negative anti-tTG in IgA deficiency)
• Over-diagnosing GH deficiency in a starved child (low IGF-1 is expected in starvation)
• Mismanaging SAM with standard ORS (should use ReSoMal) or full-strength feeds (should use F-75)
• Forgetting the refeeding syndrome risk
• Failing to recognise the safeguarding dimension of non-organic FTT [1]

Summary Algorithm

1. Recognise: weight below 3rd centile, crossing two centiles, or low velocity — plot accurately on UK-WHO charts
2. Confirm: repeat measurement, exclude error, assess velocity over time
3. Assess: structured history (feeding, birth, development, family, social), examination (growth parameters, dysmorphism, systems, safeguarding)
4. Investigate targeted: urine, FBC/ferritin, coeliac serology (+IgA), U&E/creatinine, TFTs, bone profile ± second-line guided by suspicion
5. Treat the cause if organic; nutritional rehabilitation in all cases (dietitian, energy-dense diet, supplements, NG/gastrostomy as needed)
6. MDT: paediatrician, dietitian, health visitor, SLT, psychologist, social worker
7. Safeguarding: structured assessment, refer if red flags, document
8. Severe malnutrition: WHO 10-step protocol, F-75 then F-100, prevent refeeding syndrome
9. Monitor: weekly then fortnightly then monthly; plot velocity; developmental review
10. Long-term: address psychosocial adversity, early intervention services, transition for chronic disease [1]

FTT, at its best managed, is one of the most rewarding problems in paediatrics — a child returned to their growth trajectory, with their cognition, immunity, and future restored. At its worst neglected, it is a cause of lifelong cognitive and physical disadvantage. The difference is early recognition, thorough assessment, and a coordinated multidisciplinary response — with safeguarding vigilance throughout. [1]

References

1. [1]Goodwin ET, Buel KL, Cantrell LD. Growth Faltering and Failure to Thrive in Children. Am Fam Physician, 2023.PMID 37327159